TAVI in nonagenarians, what do we know so far?
Transcatheter aortic valve implantation (TAVI) has become a widely used therapeutic strategy to treat symptomatic severe aortic stenosis. Certain randomized clinical trials available have already described the prognostic benefit of this technique in elderly patients with high or very high surgical r...
Main Authors: | Pablo Díez-Villanueva, Fernando Rivero |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2021-11-01
|
Series: | REC: Interventional Cardiology (English Ed.) |
Online Access: | https://recintervcardiol.org/en/index.php?option=com_content&view=article&id=721 |
Similar Items
-
Amyloidogenesis: What Do We Know So Far?
by: Zeina Alraawi, et al.
Published: (2022-11-01) -
Anabaenopeptins: What We Know So Far
by: Patrick Romano Monteiro, et al.
Published: (2021-07-01) -
Eosinophilic Esophagitis—What Do We Know So Far?
by: Jakub Wąsik, et al.
Published: (2023-03-01) -
Fibrocartilaginous dysplasia: What do we know so far?
by: Asma Alshalan, MD, et al.
Published: (2023-05-01) -
HIV and neoplasms: What do we know so far?
by: Thais Faria de Souza, et al.
Published: (2023-06-01)